Seller record · Telehealth service
StackMD
Fails 4 of 8 criteria. S2, prescription gating: The Start Medical Intake button on a semaglutide vial adds it to a cart, and the checkout asks for card details and charges a $39 consultation fee that day before any medical question, with the medication charged after approval. 3 more criteria also fail; see the table below.
At a glance
StackMDTelehealth service
- Price
- Semaglutide from $125, tirzepatide from $199, plus a $39 consultation fee
- Sells
- compounded semaglutide with B12 or glycine, and 10 more
- FDA letters
- None on file
Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.
A telehealth store selling compounded semaglutide and tirzepatide with B12 or glycine, oral and microdose GLP-1 options, sermorelin, NAD+ and glutathione, and a PT-141 combination tablet. The order is placed in a cart, and a consultation fee is charged at checkout before the medical questions.
Operating entity Medical 360 HC PLLC
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | StackMD's semaglutide compounded GLP-1 product page; StackMD's refund policy |
| S2 | Prescription gating | FAIL | StackMD's semaglutide compounded GLP-1 product page; StackMD's cart; StackMD's checkout |
| S3 | Pharmacy identification | FAIL | StackMD's semaglutide compounded GLP-1 product page; StackMD's medication safety page; StackMD's terms of use page |
| S4 | Compounding disclosure | PASS | StackMD's semaglutide compounded GLP-1 product page; StackMD's sermorelin compounded peptide product page |
| S5 | Analytical documentation | FAIL | StackMD's medication safety page |
| S6 | Business address | FAIL | StackMD's terms of use page; StackMD's privacy policy; StackMD's contact us page |
| S7 | Price disclosure | PASS | StackMD's weight loss category page; StackMD's semaglutide compounded GLP-1 product page; StackMD's longevity category page; StackMD's checkout |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide with B12 or glycine, compounded tirzepatide with B12 or glycine, oral tirzepatide tablets, oral semaglutide with B6 tablets, microdose GLP-1 injections, sermorelin injection and oral, NAD+ injection, oral and nasal spray, glutathione injection, oral and nasal spray, tadalafil, oxytocin and PT-141 tablet, HCG, Zepbound and Wegovy consultations.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathioneWho sells PT-141
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.